CYTK

Cytokinetics, Incorporated News Headlines

$4.45
*  
0.11
2.53%
Get CYTK Alerts
*Delayed - data as of Jul. 23, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cytokinetics: 2014 Will Bring Critical Data Readouts On Tirasemtiv And Omecamtiv Mecarbil
11/1/2013 6:37:00 PM - Seeking Alpha

Cytokinetics, Inc. Enters Oversold Territory - Tale of the Tape
10/8/2013 8:24:01 AM - Zacks.com

Why Cytokinetics Is A Strong Buy On Recent Weakness
10/7/2013 12:39:00 PM - Seeking Alpha

Cytokinetics: Presentation At Heart Failure Society Suggests Myocardial Infarctions Are Not Likely Associated With Omecamtiv Mecarbil
9/24/2013 3:37:00 PM - Seeking Alpha

Is It The Right Time To Enter Amgen?
9/18/2013 11:08:00 AM - Seeking Alpha

Amgen/Cytokinetics Drug Misses Primary Endpoint - Analyst Blog
9/5/2013 12:52:09 PM - Zacks.com

Cytokinetics: Clinical Investigators' Opinions On ATOMIC-AHF Trial Results
9/4/2013 1:02:00 PM - Seeking Alpha

Amgen to Present Data at ESC - Analyst Blog
8/28/2013 1:20:01 PM - Zacks.com

Cytokinetics: Previewing The Release Of Data From The ATOMIC-AHF Trial Of Omecamtiv Mecarbil
8/26/2013 3:33:00 PM - Seeking Alpha

Cytokinetics: Previewing The Release Of Data From The ATOMIC-AHF Trial Of Omecamtiv Mecarbil
8/26/2013 2:44:33 PM - SeekingAlpha

Cytokinetics' Tirasemtiv Data Published - Analyst Blog
8/23/2013 6:33:31 PM - Zacks.com

Healthcare Stocks Slightly Higher This Afternoon; Cytokinetics Advances After New Data Find ALS Drug Well-Tolerated
8/22/2013 2:10:32 PM - MT Newswires

Sector Update: Healthcare
8/22/2013 2:08:22 PM - MT Newswires

Loss Narrows At Idenix in Q2 - Analyst Blog
8/8/2013 12:35:33 PM - Zacks.com

Cytokinetics: A Preview Of Key Upcoming Clinical Trial Results
8/7/2013 8:39:00 PM - Seeking Alpha

Cytokinetics: A Preview Of Key Upcoming Clinical Trial Results
8/7/2013 7:43:58 PM - SeekingAlpha

Amgen - Servier Ink Deal - Analyst Blog
7/10/2013 4:57:16 PM - Zacks.com

Cytokinetics' Update on Study - Analyst Blog
7/9/2013 5:07:38 PM - Zacks.com

Unreasonable Cause For Selling Cytokinetics
7/9/2013 7:22:00 AM - Seeking Alpha

Cramer's Mad Money - Noodles & Company Is The Son Of Chipotle (7/1/13)
7/2/2013 6:00:00 AM - Seeking Alpha

Cytokinetics, Astellas Collaborate - Analyst Blog
6/26/2013 5:32:46 PM - Zacks.com

Cytokinetics: Another Positive Deal For Shareholders, This Time With Astellas
6/25/2013 12:16:00 PM - Seeking Alpha

Theravance's Vibativ Expanded in the US - Analyst Blog
6/24/2013 5:32:10 PM - Zacks.com

Amgen In Focus
6/19/2013 9:13:00 AM - Seeking Alpha

Market Wrap for Tuesday, June 18: Stocks Rally Ahead of Fed Statement
6/18/2013 4:22:20 PM - Benzinga